Hyperbaric Oxygen Treatment Decreases Cd36 Gene Expression Through HIF-1α/PPAR-γ and Reverses Non-Alcoholic Fatty Liver Disease in Rats
Undersea and Hyperbaric Medicine · 28.06.2026 · 53 (2) · 215-226
DOI: 10.22462/825 ↗Kurz gefasst
Fachartikel in der Zeitschrift Undersea and Hyperbaric Medicine, online erschienen am 28.06.2026. Verfasst von Marcos de J. Reyes Bocanegra und 15 weiteren Autor:innen.
Abstract (Originalsprache)
Reyes Bocanegra MdJ, Quintana Castro R, Páez Martínez L, Agame Lagunes B, Grube Pagola P, Hernández Leyva S, Ramírez Nava JC, Alexander Aguilera A. Hyperbaric Oxygen Treatment Decreases Cd36 Gene Expression Through HIF-1α/PPAR-γ and Reverses Non-Alcoholic Fatty Liver Disease in Rats. Undersea Hyperb Med. 2026 Second Quarter; 53(2):215-226.
Introduction
Non-alcoholic fatty liver disease (NAFLD) is characterized by the accumulation of liver fat (steatosis), which can progress to non-alcoholic steatohepatitis (NASH), cirrhosis, and cancer. NASH is estimated to affect up to 32% of the world's population. Different treatments, such as hyperbaric oxygen (HBO2), are being investigated, but the molecular mechanisms associated with this treatment are unknown. The effect of HBO2 on NAFLD associated with Cd36 expression was evaluated.
Methods
Rats were divided into the following groups: rats that developed steatosis and consumed sucrose but did not receive HBO2, rats with steatosis that consumed sucrose and received HBO2, rats that developed steatosis and received HBO2 but did not receive sucrose, and a control group. The HBO2 groups underwent the procedure for 20 days (2.4 ATA pressure 60 min). An IYOCA hyperbaric chamber model for rats was used. The expression of HIF-1α, PPAR-γ, and Cd36 mRNA from hepatic tissue was measured with the StepOne™ real-time polymerase chain reaction (PCR) system.
Results
The expression levels of hepatic HIF-1α, PPAR-γ, and Cd36 genes increased in NAFLD rats that consumed sucrose but did not receive HBO2 compared to the control group (p
Zitieren
APA
Bocanegra, M. D. J. R., BS, Castro, R. Q., PhD, Martínez, L. P., BS, Lagunes, B. A., PhD, Pagola, P. G., PhD, Leyva, S. H., PhD, Nava, J. R., MSc, Aguilera, A. A., & PhD (2026). Hyperbaric Oxygen Treatment Decreases Cd36 Gene Expression Through HIF-1α/PPAR-γ and Reverses Non-Alcoholic Fatty Liver Disease in Rats. Undersea and Hyperbaric Medicine, 53(2), 215-226. https://doi.org/10.22462/825
Vancouver
Bocanegra MDJR, BS, Castro RQ, PhD, Martínez LP, BS, et al. Hyperbaric Oxygen Treatment Decreases Cd36 Gene Expression Through HIF-1α/PPAR-γ and Reverses Non-Alcoholic Fatty Liver Disease in Rats. Undersea and Hyperbaric Medicine. 2026;53(2):215-226. doi:10.22462/825
BibTeX
@article{Bocanegra2026,
author = {Bocanegra, Marcos de J. Reyes and BS and Castro, Rodolfo Quintana and PhD and Martínez, Luis Páez and BS and Lagunes, Beatriz Agame and PhD and Pagola, Peter Grube and PhD and Leyva, Sandra Hernández and PhD and Nava, Julio Ramírez and MSc and Aguilera, Alfonso Alexander and PhD},
title = {Hyperbaric Oxygen Treatment Decreases Cd36 Gene Expression Through HIF-1α/PPAR-γ and Reverses Non-Alcoholic Fatty Liver Disease in Rats},
journal = {Undersea and Hyperbaric Medicine},
year = {2026},
volume = {53},
number = {2},
pages = {215--226},
doi = {10.22462/825}
}
EUVIMED